219 related articles for article (PubMed ID: 37175654)
1. Pro-Inflammatory Priming of the Brain: The Underlying Cause of Parkinson's Disease.
Martins AC; Lima IS; Pêgo AC; Sá Pereira I; Martins G; Kapitão A; Gozzelino R
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175654
[TBL] [Abstract][Full Text] [Related]
2. Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease.
Kip E; Parr-Brownlie LC
Ageing Res Rev; 2022 Jun; 78():101618. PubMed ID: 35395416
[TBL] [Abstract][Full Text] [Related]
3. [Research progress on neural mechanism of peripheral inflammation in Parkinson's disease].
Liu YT; Sun MH; Cai CW; Ren C; Niu HC
Sheng Li Xue Bao; 2019 Oct; 71(5):732-740. PubMed ID: 31646327
[TBL] [Abstract][Full Text] [Related]
4. Calpain activation and progression of inflammatory cycles in Parkinson's disease.
Gao A; McCoy HM; Zaman V; Shields DC; Banik NL; Haque A
Front Biosci (Landmark Ed); 2022 Jan; 27(1):20. PubMed ID: 35090325
[TBL] [Abstract][Full Text] [Related]
5. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease.
Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY
Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation in Parkinson's Disease and its Treatment Opportunities.
Çınar E; Tel BC; Şahin G
Balkan Med J; 2022 Sep; 39(5):318-333. PubMed ID: 36036436
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
9. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J; Elgueta D; Pacheco R
Front Immunol; 2019; 10():239. PubMed ID: 30828335
[TBL] [Abstract][Full Text] [Related]
10. Demethylenetetrahydroberberine protects dopaminergic neurons in a mouse model of Parkinson's disease.
Wen J; Zhang YQ; Liu DQ; Yao XT; Jiang H; Zhang YB
Chin J Nat Med; 2022 Feb; 20(2):111-119. PubMed ID: 35279238
[TBL] [Abstract][Full Text] [Related]
11. Role of chemokines in Parkinson's disease.
Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH
Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787
[TBL] [Abstract][Full Text] [Related]
12. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
[TBL] [Abstract][Full Text] [Related]
13. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
[TBL] [Abstract][Full Text] [Related]
14. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
[TBL] [Abstract][Full Text] [Related]
15. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
[TBL] [Abstract][Full Text] [Related]
16. The role of Toll-like receptors and neuroinflammation in Parkinson's disease.
Heidari A; Yazdanpanah N; Rezaei N
J Neuroinflammation; 2022 Jun; 19(1):135. PubMed ID: 35668422
[TBL] [Abstract][Full Text] [Related]
17. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation.
de Pablos RM; Herrera AJ; Espinosa-Oliva AM; Sarmiento M; Muñoz MF; Machado A; Venero JL
J Neuroinflammation; 2014 Feb; 11():34. PubMed ID: 24565378
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
[TBL] [Abstract][Full Text] [Related]
19. Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.
Riederer P; Monoranu C; Strobel S; Iordache T; Sian-Hülsmann J
J Neural Transm (Vienna); 2021 Oct; 128(10):1577-1598. PubMed ID: 34636961
[TBL] [Abstract][Full Text] [Related]
20. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage.
Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP
Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
